Effects of Training Frequency on Patellofemoral Pain Rehabilitation.
ETFRPPRRCT
Comparison of the Effects of Different Training Frequencies on the Rehabilitation of Individuals with Patellofemoral Pain: a Randomized Clinical Trial
1 other identifier
interventional
84
1 country
1
Brief Summary
This clinical trial aims to determine the optimal frequency of exercise therapy for improving pain, function, and quality of life in participants with patellofemoral pain. The main questions it aims to answer are: Does exercising twice a week provide the same benefits as exercising three times a week for individuals with patellofemoral pain? What are the optimal dosage, volume, and weekly exercise frequency for treating patellofemoral pain? The investigators will compare two groups of participants: one group of participants receiving exercise therapy twice a week and another group receiving exercise therapy three times a week. Both groups will follow the same exercise protocol targeting the muscles of the hip and knee joints. Participants: 84 volunteers (both male and female) with patellofemoral pain Physically active individuals aged between 18 and 40 years Interventions: Participants will be randomly assigned to one of two groups Both groups will perform the same exercises for hip and knee muscle strengthening Group A will exercise three times per week Group B will exercise two times per week The intervention will last for six consecutive weeks Assessments: Participants will be evaluated at the following time points: Before the intervention After the 4th and 6th week of intervention 6 months and 1 year after the end of the intervention The primary Outcome Measure will be pain intensity. Secondary Outcome Measure: Anterior knee pain during daily activities Kinesiophobia Pain-related self-efficacy Chronic pain-related self-efficacy Catastrophizing Muscle strength 3D Movement analysis Data Analysis: The investigators will use an intention-to-treat analysis, which means that all participants will be included in the study, regardless of whether they completed the treatment as planned. Appropriate statistical tests will be used to compare differences within and between the two groups, considering the time points and group factors. A 5% significance level will be adopted, which means there is a 5% chance that the results are due to random variation rather than the treatment effect.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 28, 2025
CompletedFirst Posted
Study publicly available on registry
February 5, 2025
CompletedStudy Start
First participant enrolled
February 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 21, 2026
February 5, 2025
February 1, 2025
1.8 years
January 28, 2025
February 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain intensity
Visual Analog Pain Scale: This scale aims to quantify the intensity of pain experienced by the patient. The scale consists of 11 points, with a score classification from 0 to 10. A score of 0 represents "no pain at all", and 10 means "the worst pain possible". Patients will be asked to rate their anterior knee pain intensity levels based on the past fifteen days. The minimum clinically important difference for improvement will be a decrease of 1 point on the scale.
Evaluations will occur at five time frames: 24 hours before the first treatment session, after the 4th and 6th weeks of treatment, and 6 months and 1 year after the last session.
Secondary Outcomes (8)
Anterior Knee Pain Scale
24 hours before the first treatment session, after the 4th and 6th weeks of treatment, and 6 months and 1 year after the last session.
Tampa Scale for Kinesiophobia
24 hours before the first treatment session, after the 4th and 6th weeks of treatment, and 6 months and 1 year after the last session.
Pain Self-Efficacy Questionnaire
24 hours before the first treatment session, after the 4th and 6th weeks of treatment, and 6 months and 1 year after the last session.
Chronic Pain Self-Efficacy Scale
24 hours before the first treatment session, after the 4th and 6th weeks of treatment, and 6 months and 1 year after the last session.
Pain Catastrophizing Scale
24 hours before the first treatment session, after the 4th and 6th weeks of treatment, and 6 months and 1 year after the last session.
- +3 more secondary outcomes
Study Arms (2)
Strengthening 2 times per week
EXPERIMENTALThis group will consist of participants with patellofemoral pain and will receive treatment twice a week.
Strengthening 3 times per week
OTHERThis group will consist of participants with patellofemoral pain and will receive treatment twice a week.
Interventions
This group will consist of participants with patellofemoral pain and will receive treatment twice a week.
This group will consist of participants with patellofemoral pain and will receive treatment thrice a week.
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nove de Julho University
São Paulo, São Paulo, 01.504-001, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
PAULO RG LUCARELI, PhD
Nove de Julho University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Human Movement Analysis Laboratory
Study Record Dates
First Submitted
January 28, 2025
First Posted
February 5, 2025
Study Start
February 24, 2025
Primary Completion (Estimated)
November 30, 2026
Study Completion (Estimated)
December 21, 2026
Last Updated
February 5, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share